Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

New double inequalities for g-frames in Hilbert [Formula: see text]-modules.

Xiang ZQ.

Springerplus. 2016 Jul 8;5(1):1025. doi: 10.1186/s40064-016-2731-2. eCollection 2016.

2.

Protection of non-human primates against rabies with an adenovirus recombinant vaccine.

Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE.

Virology. 2014 Feb;450-451:243-9. doi: 10.1016/j.virol.2013.12.029. Epub 2014 Jan 9.

3.

[Effects of sub-micro emulsion composition on cellular disposition of incorporated lipophilic drug].

Sun XY, Xiang ZQ, Wu S, Lv YY, Liang WQ.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013 Sep;42(5):523-9. Chinese.

PMID:
24167133
4.

B cell responses to the 2011/12-influenza vaccine in the aged.

Kurupati RK, Kannan S, Xiang ZQ, Doyle S, Ratcliffe S, Schmader KE, Ertl HC.

Aging (Albany NY). 2013 Mar;5(3):209-26.

5.

Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.

Azzoni L, Foulkes AS, Firnhaber C, Yin X, Xiang ZQ, Li Y, Stevens W, Gross R, Ertl HC, Sanne I, Montaner LJ.

AIDS. 2012 Jul 17;26(11):1355-62. doi: 10.1097/QAD.0b013e328354648e.

6.

Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.

Chen H, Xiang ZQ, Li Y, Kurupati RK, Jia B, Bian A, Zhou DM, Hutnick N, Yuan S, Gray C, Serwanga J, Auma B, Kaleebu P, Zhou X, Betts MR, Ertl HC.

J Virol. 2010 Oct;84(20):10522-32. doi: 10.1128/JVI.00450-10. Epub 2010 Aug 4.

7.

Xeno-free culture of human spermatogonial stem cells supported by human embryonic stem cell-derived fibroblast-like cells.

Chen B, Wang YB, Zhang ZL, Xia WL, Wang HX, Xiang ZQ, Hu K, Han YF, Wang YX, Huang YR, Wang Z.

Asian J Androl. 2009 Sep;11(5):557-65. doi: 10.1038/aja.2009.21. Epub 2009 Aug 17.

8.

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens.

Tatsis N, Lasaro MO, Lin SW, Haut LH, Xiang ZQ, Zhou D, Dimenna L, Li H, Bian A, Abdulla S, Li Y, Giles-Davis W, Engram J, Ratcliffe SJ, Silvestri G, Ertl HC, Betts MR.

J Immunol. 2009 May 15;182(10):6587-99. doi: 10.4049/jimmunol.0900317. Erratum in: J Immunol. 2009 Dec 1;183(11):7611. Haut, Larissa H [added].

9.

A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.

Li H, Lin SW, Giles-Davis W, Li Y, Zhou D, Xiang ZQ, High KA, Ertl HC.

Mol Ther. 2009 Jul;17(7):1215-24. doi: 10.1038/mt.2009.79. Epub 2009 Apr 14.

10.

[The feeder layer of human embryonic fibroblasts supports the growth of human spermatogonial stem cells].

Wang YB, Chen B, Wang YC, Zhang ZL, Wang HX, Lu YN, Xiang ZQ, Hu K, Yang YK, Han YF, Wang Z, Wang YX, Huang YR.

Zhonghua Nan Ke Xue. 2008 Dec;14(12):1063-8. Chinese.

PMID:
19157223
11.

Leptin and varicocele-related spermatogenesis dysfunction: animal experiment and clinical study.

Chen B, Guo JH, Lu YN, Ying XL, Hu K, Xiang ZQ, Wang YX, Chen P, Huang YR.

Int J Androl. 2009 Oct;32(5):532-41. doi: 10.1111/j.1365-2605.2008.00892.x. Epub 2008 May 14.

PMID:
18484972
12.

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC.

Blood. 2007 Sep 15;110(6):1916-23. Epub 2007 May 17.

13.

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

Tatsis N, Blejer A, Lasaro MO, Hensley SE, Cun A, Tesema L, Li Y, Gao GP, Xiang ZQ, Zhou D, Wilson JM, Ertl HC.

Mol Ther. 2007 Mar;15(3):608-17. Epub 2007 Jan 16.

14.

[Effects of growth hormone supplementation on erectile function and expression of nNOS in aging rats].

Zhang XS, Wang YX, Han YF, Li Z, Xiang ZQ, Leng J, Huang XY.

Zhonghua Nan Ke Xue. 2005 May;11(5):339-42. Chinese.

PMID:
15934455
15.

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.

Reyes-Sandoval A, Fitzgerald JC, Grant R, Roy S, Xiang ZQ, Li Y, Gao GP, Wilson JM, Ertl HC.

J Virol. 2004 Jul;78(14):7392-9.

16.

[Seminal plasma angiotensin II detection and its clinical implication].

Zheng S, Li Z, Wang YX, Xiang ZQ.

Zhonghua Nan Ke Xue. 2003 Dec;9(9):669-72. Chinese.

PMID:
14727354
17.

[Experimental research on human spermatozoa membrane proteins by two-dimensional gel electrophoresis].

Wang HF, Xiang ZQ, Wang YX.

Zhonghua Nan Ke Xue. 2003 Oct;9(7):504-6. Chinese.

PMID:
14628597
18.

Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.

Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HC.

J Virol. 2003 Oct;77(20):10780-9. Erratum in: J Virol. 2005 Mar;79(6):3888.

19.

[Measurement of the reactive oxygen species and cytokines in the seminal plasma of leukocytospermic patients].

Liu J, Wang YX, Wu YL, Qian XM, Xiang ZQ.

Zhonghua Nan Ke Xue. 2003 Apr;9(2):103-5. Chinese.

PMID:
12749127
20.
21.
22.

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

Fitzgerald JC, Gao GP, Reyes-Sandoval A, Pavlakis GN, Xiang ZQ, Wlazlo AP, Giles-Davis W, Wilson JM, Ertl HC.

J Immunol. 2003 Feb 1;170(3):1416-22.

23.

Development of novel antibacterial peptides that kill resistant isolates.

Cudic M, Condie BA, Weiner DJ, Lysenko ES, Xiang ZQ, Insug O, Bulet P, Otvos L Jr.

Peptides. 2002 Dec;23(12):2071-83.

PMID:
12535685
24.

[The effects of testosterone undecanoate on relaxation of rat corpus cavernosum smooth muscle in vitro].

Li Z, Wang YX, Zheng S, Xiang ZQ, Han YF.

Zhonghua Nan Ke Xue. 2002;8(2):130-3. Chinese.

PMID:
12479030
25.

Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

Cohen CJ, Xiang ZQ, Gao GP, Ertl HC, Wilson JM, Bergelson JM.

J Gen Virol. 2002 Jan;83(Pt 1):151-5.

PMID:
11752711
26.

Replication-defective vector based on a chimpanzee adenovirus.

Farina SF, Gao GP, Xiang ZQ, Rux JJ, Burnett RM, Alvira MR, Marsh J, Ertl HC, Wilson JM.

J Virol. 2001 Dec;75(23):11603-13.

27.

A method that allows easy characterization of tumor-infiltrating lymphocytes.

Kowalczyk DW, Wlazlo AP, Blaszczyk-Thurin M, Xiang ZQ, Giles-Davis W, Ertl HC.

J Immunol Methods. 2001 Jul 1;253(1-2):163-75.

PMID:
11384678
28.

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.

He Z, Wlazlo AP, Kowalczyk DW, Cheng J, Xiang ZQ, Giles-Davis W, Ertl HC.

Virology. 2000 Apr 25;270(1):146-61.

30.

A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.

Otvos L Jr, Hoffmann R, Xiang ZQ, O I, Deng H, Wysocka M, Pease AM, Rogers ME, Blaszczyk-Thurin M, Ertl HC.

Biochim Biophys Acta. 1998 Sep 16;1404(3):457-74.

31.

The effect of interferon-gamma on genetic immunization.

Xiang ZQ, He Z, Wang Y, Ertl HC.

Vaccine. 1997 Jun;15(8):896-8.

PMID:
9234542
32.

Genetic vaccines--a revolution in vaccinology?

Xiang ZQ, Pasquini S, He Z, Deng H, Wang Y, Blaszczyk-Thurin MA, Ertl HC.

Springer Semin Immunopathol. 1997;19(2):257-68. Review. No abstract available.

PMID:
9406351
33.

The effects of post-translational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopes.

Otvos L Jr, Cappelletto B, Varga I, Wade JD, Xiang ZQ, Kaiser K, Stephens LJ, Ertl HC.

Biochim Biophys Acta. 1996 Aug 21;1313(1):11-9.

34.

Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines.

Ertl HC, Varga I, Xiang ZQ, Kaiser K, Stephens L, Otvos L Jr.

Vaccine. 1996 Jun;14(9):879-85.

PMID:
8843629
35.

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

Xiang ZQ, Yang Y, Wilson JM, Ertl HC.

Virology. 1996 May 1;219(1):220-7.

36.

Genetic immunization.

Ertl HC, Xiang ZQ.

Viral Immunol. 1996;9(1):1-9. Review.

PMID:
8733914
37.

Immune effector mechanisms required for protection to rabies virus.

Xiang ZQ, Knowles BB, McCarrick JW, Ertl HC.

Virology. 1995 Dec 20;214(2):398-404.

38.

Plasmid vectors as anti-viral vaccines.

Ertl HC, Verma P, He Z, Xiang ZQ.

Ann N Y Acad Sci. 1995 Nov 27;772:77-87. No abstract available.

PMID:
8546415
39.

Immune responses to nucleic acid vaccines to rabies virus.

Xiang ZQ, Spitalnik SL, Cheng J, Erikson J, Wojczyk B, Ertl HC.

Virology. 1995 Jun 1;209(2):569-79.

40.
41.

Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion.

Wojczyk B, Shakin-Eshleman SH, Doms RW, Xiang ZQ, Ertl HC, Wunner WH, Spitalnik SL.

Biochemistry. 1995 Feb 28;34(8):2599-609.

PMID:
7873541
42.

Glycosylation of synthetic T helper cell epitopic peptides influences their antigenic potency and conformation in a sugar location-specific manner.

Otvos L Jr, Urge L, Xiang ZQ, Krivulka GR, Nagy L, Szendrei GI, Ertl HC.

Biochim Biophys Acta. 1994 Oct 20;1224(1):68-76.

PMID:
7524686
43.

A simple method to test the ability of individual viral proteins to induce immune responses.

Xiang ZQ, Ertl HC.

J Virol Methods. 1994 Apr;47(1-2):103-16.

PMID:
8051219
44.

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC.

Virology. 1994 Feb 15;199(1):132-40.

PMID:
8116236
45.

Supplemental Content

Loading ...
Support Center